To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
31.46 kg wood
1.69 g CO2
28.56 ml Water
Share this page
Advancements in Tumor Immunotherapy and Cancer Vaccines
Edited by Hilal Arnouk, ISBN 978-953-307-998-1, Hard cover, 218 pages, Publisher: InTech, Published: February 03, 2012 under CC BY 3.0 license, in subject Immunology, Allergology and Rheumatology
DOI: 10.5772/1453
Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.
This book is indexed in:
Book contents
- Chapter 1Immunotherapy in Urologic Malignancies: The Evolution and Future of Pattern Recognition Receptors
- Chapter 2Vaccine and Cancer Therapy for Genitourinary Tumors
- Chapter 3Challenges to Prostate Cancer Immunotherapy
- Chapter 4Prostate Cancer Immunotherapy – Strategy with a Synthetic GnRH Based Vaccine Candidate
- Chapter 5Immune-Therapy in Cutaneous Melanoma – Efficacy Immune Markers
- Chapter 6Innate Immunity-Based Immunotherapy of Cancer
- Chapter 7The Potential Use of Triterpene Compounds in Dendritic Cells-Based Immunotherapy
- Chapter 8The Novel Use of Zwitterionic Bacterial Components and Polysaccharides in Immunotherapy of Cancer and Immunosuppressed Cancer Patients
- Chapter 9Type III Interferons IL-28 and IL-29: Novel Interferon Family Members with Therapeutic Potential in Cancer Therapy
- Chapter 10Interleukin 12: Stumbling Blocks and Stepping Stones to Effective Anti-Tumor Therapy
